Free shipping on all orders over $ 500

Vesnarinone

Cat. No. M10179

All AbMole products are for research use only, cannot be used for human consumption.

Vesnarinone Structure
Synonym:

OPC-8212; Piteranometozine; Arkin

Size Price Availability Quantity
10mg USD 140  USD140 In stock
25mg USD 230  USD230 In stock
50mg USD 410  USD410 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Vesnarinone is a cardiotonic agent, mixed phosphodiesterase 3 inhibitor and ion-channel modifier that has modest, dose-dependent, positive inotropic activity. Vesnarinone improves ventricular performance most in patients with the worst degree of heart failure.

Chemical Information
Molecular Weight 395.45
Formula C22H25N3O4
CAS Number 81840-15-5
Solubility (25°C) DMSO ≥ 10 mM
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Kentaro Hotta, et al. Mol Pharmacol. Vesnarinone suppresses TNFα mRNA expression by inhibiting valosin-containing protein

[2] Minoru Inage, et al. Int J Biol Sci. Vesnarinone represses the fibrotic changes in murine lung injury induced by bleomycin

[3] Y Katayama, et al. J Pharmacol Exp Ther. Inhibitory effects of vesnarinone on cloned cardiac delayed rectifier K(+) channels expressed in a mammalian cell line

[4] E Cavusoglu, et al. J Card Fail. Vesnarinone: a new inotropic agent for treating congestive heart failure

[5] A Matsumori, et al. Circulation. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

Related PDE Products
MR-L2

MR-L2 is a reversible and noncompetitive allosteric activator of long-isoform phosphodiesterase-4 (PDE4), activates representative PDE4 long-isoform variants (PDE4A4, PDE4B1, PDE4C3, PDE4D5). MR-L2 suppresses PGE2-induced MDCK cell cyst formation with an EC50 of 1.2 μM.

MMPX

MMPX is a potent PDE1 inhibitor.

T-0156 

T-0156 is a potent and selective phosphodiesterase type 5 (PDE5) inhibitor.

TPN171 

TPN171 is a potent, selective and oral bioavailable inhibitor of phosphodiesterase type 5 (PDE5) with an IC50 of 0.62 nM, being developed for the treatment of pulmonary arterial hypertension (PAH).

Mesopram

Mesopram (Daxalipram) is an orally active phosphodiesterase (PDE) 4 inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Vesnarinone, OPC-8212; Piteranometozine; Arkin supplier, PDE, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.